AVNR Financial Facts
Loss from operations: -15.48MBasic and diluted net loss per share: -0.12
See Full Income Statement
Non-current inventories: 908.37K
Property and equipment, net: 1.68M
See Full Balance Sheet
Earnings History for Avanir Pharma (AVNR)
|
Expand Research on AVNR
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +25.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -11.5% | Revenue Growth Rate | +129.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/13  |
 |
Q113 | -$0.12 | -$0.09 | -$0.03 | $17.4M | $17.4M | N/A / N/A | N/A | +6.3% | Details |
| 2/7/13 |
|
Q113 | -$0.09 | -$0.08 | -$0.01 | $16.5M | $7.2M | N/A / N/A | N/A | +17.5% | Details |
| 12/12/12 |
|
Q412 | -$0.09 | -$0.09 | $0.00 | $13.5M | $12.9M | N/A / N/A | N/A | +30.4% | Details |
| 5/8/12 |
|
Q212 | -$0.13 | -$0.12 | -$0.01 | $10M | $7.81M | N/A / N/A | N/A | +19.6% | Details |
| 8/8/12 |
Q212 | -$0.11 | -$0.11 | $0.00 | $10.1M | $10.29M | N/A / N/A | N/A | +15.5% | Details | |
| 2/7/12 |
|
Q112 | -$0.12 | -$0.13 | +$0.01 | $7.2M | $6.49M | N/A / N/A | N/A | +5.7% | Details |
| 12/12/11 |
|
Q411 | -$0.14 | -$0.14 | $0.00 | $4.8M | $4.49M | N/A / N/A | N/A | +45.7% | Details |
| 8/8/11 |
|
Q311 | -$0.13 | -$0.14 | +$0.01 | $2.5M | $2.53M | N/A / N/A | N/A | +7.7% | Details |
